首页> 美国卫生研究院文献>other >MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing
【2h】

MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing

机译:爱泼斯坦 - 巴尔病毒相关NK / T细胞淋巴瘤的microRNa分析谱由深度测序

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Epstein-Barr virus (EBV) is an oncogenic human Herpes virus involved in the pathogenesis of nasal NK/T-cell lymphoma. EBV encodes microRNAs (miRNAs) and induces changes in the host cellular miRNA profile. MiRNAs are short non-coding RNAs of about 19–25 nt length that regulate gene expression by post-transcriptional mechanisms and are frequently deregulated in human malignancies including cancer. The microRNA profiles of EBV-positive NK/T-cell lymphoma, non-infected T-cell lymphoma and normal thymus were established by deep sequencing of small RNA libraries. The comparison of the EBV-positive NK/T-cell vs. EBV-negative T-cell lymphoma revealed 15 up- und 16 down-regulated miRNAs. In contrast, the majority of miRNAs was repressed in the lymphomas compared to normal tissue. We also identified 10 novel miRNAs from known precursors and two so far unknown miRNAs. The sequencing results were confirmed for selected miRNAs by quantitative Real-Time PCR (qRT-PCR). We show that the proinflammatory cytokine interleukin 1 alpha (IL1A) is a target for miR-142-3p and the oncogenic BCL6 for miR-205. MiR-142-3p is down-regulated in the EBV-positive vs. EBV-negative lymphomas. MiR-205 was undetectable in EBV-negative lymphoma and strongly down-regulated in EBV-positive NK/T-cell lymphoma as compared to thymus. The targets were confirmed by reporter assays and by down-regulation of the proteins by ectopic expression of the cognate miRNAs. Taken together, our findings demonstrate the relevance of deregulated miRNAs for the post-transcriptional gene regulation in nasal NK/T-cell lymphomas.
机译:爱泼斯坦-巴尔病毒(EBV)是一种致癌性人疱疹病毒,与鼻NK / T细胞淋巴瘤的发病机理有关。 EBV编码microRNA(miRNA),并诱导宿主细胞miRNA图谱发生变化。 MiRNA是大约19–25 nt长度的短非编码RNA,可通过转录后机制调节基因表达,并经常在包括癌症在内的人类恶性肿瘤中失控。 EBV阳性NK / T细胞淋巴瘤,未感染的T细胞淋巴瘤和正常胸腺的microRNA图谱是通过对小RNA文库进行深度测序而建立的。 EBV阳性NK / T细胞与EBV阴性T细胞淋巴瘤的比较显示出15种上调和16种下调的miRNA。相反,与正常组织相比,大多数miRNA在淋巴瘤中被抑制。我们还从已知的前体中鉴定出了10种新颖的miRNA,迄今为止还鉴定了两种未知的miRNA。通过定量实时PCR(qRT-PCR)确认了所选miRNA的测序结果。我们显示促炎细胞因子白介素1α(IL1A)是miR-142-3p和miR-205的致癌BCL6的目标。在EBV阳性与EBV阴性的淋巴瘤中,MiR-142-3p被下调。与胸腺相比,在EBV阴性淋巴瘤中未检测到MiR-205,并且在EBV阳性NK / T细胞淋巴瘤中强烈下调了MiR-205。通过报道分子测定和通过同源miRNA的异位表达对蛋白质的下调来确认靶标。综上所述,我们的发现证明了在鼻NK / T细胞淋巴瘤中,miRNA的失调与转录后基因调控的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号